Axogen, Inc. cotiza a 36.17 USD y tiene una capitalización bursátil de $2.1B. En los últimos 12 meses ha facturado $251M con un margen de flujo de caja libre del -1.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguar…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.12 | $0.07 | $0.07 |
| Estimado | $0.13 | $0.12 | $0.07 | $0.10 |
| Sorpresa | — | +0.0% | +0.0% | -30.0% |
| Métrica | AXGN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 74.3% | 57.0% | +17.3% |
| Operating Margin | -3.5% | -38.6% | +35.1% |
| Net Margin | -7.0% | -33.6% | +26.6% |
| FCF Margin | -1.3% | -13.9% | +12.6% |
| ROE | -12.2% | -40.4% | +28.2% |
| ROA | -7.1% | -32.0% | +24.9% |
| Current Ratio | 5.11 | 2.84 | +2.27 |
| Debt / Equity | 0.38 | 0.28 | +0.10 |